Top of the morning to you. A sunny day is unfolding here on the Pharmalot corporate campus where, once again, we are hustling the short people off to the school house. And then we will catch up on reading some interesting documents. What about you? Meetings and deadlines beckon? Of course. To help you along, here are some tidbits from around the world. Have a great day, everyone...
Genzyme In Talks To Conduct R&D In Russia (Reuters)
UK's NICE Backs Simponi Rheumatoid Arthritis Med (Dow Jones)
CMS Declines To Change Coverage For Anemia Meds (Reuters)
ITC To Probe Lilly Infringement Claim (Indianapolis Business Journal)
Pfizer Reaches Tax Deal With School District (LoHud)
Ireland Plans Pharma Research Center (Irish Independent)
CALPERS Ends Talks With Medco (Associated Press)
Pfizer Director Sells Stock After Multi-Year High (Barron's)
Sanofi-Aventis And Genfit Sign Discovery Deal (Reuters)
Amylin And Takeda Suspend Obesity Study (Xconomy)
Depomed And Abbott End Shingles Drug Deal (Dow Jones)
UK Hopes To Attract CROs To Pfizer Sandwich Site (Pharma Times)
Actelion Is Pressured Over Strategy (Dow Jones)
Primatene OTC To Be Discontinued (Drug Store News)
1 Comment
"And the rest of the day to you, Mr Ed!"
Beannacht Lá Fhéile Pádraig!